What is Eyeleve?
Bruder Healthcare, the entity behind Eyeleve, specializes in advanced eye care solutions. Their flagship product, Eyeleve MGD, is a preservative-free eye drop engineered to offer robust moisturization, lubrication, and protection for individuals experiencing moderate to severe evaporative dry eye. The product line is designed for both professional and consumer use, targeting conditions such as Meibomian Gland Dysfunction (MGD), blepharitis, and allergies. Eyeleve's formulations are rich in moisture, aiming to deliver soothing and irritation relief, thereby supporting overall eye health and wellness.
How much funding has Eyeleve raised?
Eyeleve has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Eyeleve?
The substantial late-stage funding positions Eyeleve for accelerated growth and market penetration. This strategic investment is likely to fuel further research and development, enhance manufacturing capabilities, and expand distribution channels. The company's focus on addressing prevalent dry eye conditions, particularly MGD, aligns with a growing market demand for effective and specialized ocular treatments. Eyeleve is poised to solidify its market presence and potentially introduce new innovations in eye care.
See full Eyeleve company page
